✨ Medicines Act Notices




788

NEW ZEALAND GAZETTE

No. 30

Health

Medicines Act 1981

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Invirase

Active Ingredient: Saquinavir mesylate 228.7mg equivalent to 200mg Saquinavir free base

Dosage Form: Capsule

New Zealand Sponsor: Roche Products (New Zealand) Limited

Manufacturers: F Hoffmann-La Roche AG, Basel, Switzerland
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America

Note: This consent is valid for 2 years from 6 June 2002.

Dated this 22nd day of March 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go2118

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Dysport

Active Ingredient: Clostridium botulinum type A toxin haemagglutinin complex 500U

Dosage Form: Powder for injection

New Zealand Sponsor: New Zealand Medical & Scientific Limited

Manufacturer: Ispen Limited, Wrexham Industrial Estate, Clwyd, United Kingdom

Dated this 22nd day of March 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go2117

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: NeutraGard Plus (Tropical Blast flavour)

Active Ingredient: Sodium fluoride 0.2%w/v

Dosage Form: Topical solution

New Zealand Sponsor: Ivoclar Vivadent Limited

Manufacturer: Pascal Company Inc, Bellevue, Washington, United States of America

Product: NeutraGard Plus (Mint flavour)

Active Ingredient: Sodium fluoride 0.2%w/v

Dosage Form: Topical solution

New Zealand Sponsor: Ivoclar Vivadent Limited

Manufacturer: Pascal Company Inc, Bellevue, Washington, United States of America



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2002, No 30


Gazette.govt.nz PDF NZ Gazette 2002, No 30





✨ LLM interpretation of page content

πŸ₯ Renewal of Provisional Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
22 March 2002
Medicines, Provisional Consent, Invirase, Saquinavir mesylate, Roche Products
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
22 March 2002
Medicines, Consent, Dysport, Clostridium botulinum toxin, New Zealand Medical & Scientific Limited
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
22 March 2002
Medicines, Consent, NeutraGard Plus, Sodium fluoride, Ivoclar Vivadent Limited
  • G. R. Boyd, Chief Advisor, Safety and Regulation